MY6200051A - 6-chloro-7-sulphamyl-3:4-dihydro-1:2:3-benzothiadiazine-1:1-dioxide and its salts and the preparation thereof - Google Patents

6-chloro-7-sulphamyl-3:4-dihydro-1:2:3-benzothiadiazine-1:1-dioxide and its salts and the preparation thereof

Info

Publication number
MY6200051A
MY6200051A MY51/62A MY6200051A MY6200051A MY 6200051 A MY6200051 A MY 6200051A MY 51/62 A MY51/62 A MY 51/62A MY 6200051 A MY6200051 A MY 6200051A MY 6200051 A MY6200051 A MY 6200051A
Authority
MY
Malaysia
Prior art keywords
sulphamyl
benzothiadiazine
dihydro
chloro
dioxide
Prior art date
Application number
MY51/62A
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of MY6200051A publication Critical patent/MY6200051A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/261,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/281,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/261,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/301,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MY51/62A 1958-03-03 1962-12-30 6-chloro-7-sulphamyl-3:4-dihydro-1:2:3-benzothiadiazine-1:1-dioxide and its salts and the preparation thereof MY6200051A (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US71845258A 1958-03-03 1958-03-03
US72724258A 1958-04-09 1958-04-09
US74058258A 1958-06-09 1958-06-09
US75162058A 1958-07-29 1958-07-29
US76448258A 1958-09-29 1958-09-29
DEC0028408 1959-02-27
DEC0028409 1959-02-27
DEC0024176 1959-02-27
DEC0024178 1959-02-27
DEC0024177 1959-02-27

Publications (1)

Publication Number Publication Date
MY6200051A true MY6200051A (en) 1962-12-31

Family

ID=27579177

Family Applications (1)

Application Number Title Priority Date Filing Date
MY51/62A MY6200051A (en) 1958-03-03 1962-12-30 6-chloro-7-sulphamyl-3:4-dihydro-1:2:3-benzothiadiazine-1:1-dioxide and its salts and the preparation thereof

Country Status (6)

Country Link
CH (4) CH371454A (en)
DE (4) DE1445005A1 (en)
FR (2) FR1217929A (en)
GB (1) GB861367A (en)
MY (1) MY6200051A (en)
OA (2) OA01178A (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3200117A (en) * 1962-10-03 1965-08-10 Hoffmann La Roche Derivatives of 1, 2, 4-benzothiadiazine-7-sulfonamide-1, 1-dioxide
DE2642140C2 (en) * 1976-09-20 1982-10-28 Degussa Ag, 6000 Frankfurt Process for the production of benzoyl cyanide
DE8700284U1 (en) * 1987-01-07 1987-04-30 Ernst Reiner GmbH & Co KG, 7743 Furtwangen Post date stamp
US6943159B1 (en) 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
RU2214405C2 (en) * 1998-02-18 2003-10-20 НьюроСёрч А/С Novel compounds and their application as positive modulators of ampa-receptors
ES2362998T3 (en) 2002-08-19 2011-07-18 Pfizer Inc. COMBINATION THERAPY FOR HYPERPROLIFERATIVE DISEASES.
JP4589919B2 (en) 2003-03-07 2010-12-01 シェーリング コーポレイション Substituted azetidinone compounds, their formulations and uses for the treatment of hypercholesterolemia
ATE406364T1 (en) 2003-03-07 2008-09-15 Schering Corp SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
BR112015030326A2 (en) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc ULTRAPURE GUANYLATE CYCLASE C AGONISTS, METHOD OF MANUFACTURING AND USING THEM
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (en) 2019-01-18 2021-08-19 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof.

Also Published As

Publication number Publication date
CH387642A (en) 1965-02-15
DE1445008A1 (en) 1968-10-24
DE1445574A1 (en) 1969-01-16
FR1264468A (en) 1961-06-23
CH376514A (en) 1964-04-15
GB861367A (en) 1961-02-22
CH371454A (en) 1963-08-31
CH377365A (en) 1964-05-15
DE1112079B (en) 1961-08-03
DE1445006A1 (en) 1968-10-24
FR1217929A (en) 1960-05-06
OA03826A (en) 1971-12-24
DE1445005A1 (en) 1968-10-24
DE1445006B2 (en) 1975-05-07
DE1445007A1 (en) 1968-10-24
OA01178A (en) 1969-01-25

Similar Documents

Publication Publication Date Title
MY6200051A (en) 6-chloro-7-sulphamyl-3:4-dihydro-1:2:3-benzothiadiazine-1:1-dioxide and its salts and the preparation thereof
MY6400051A (en) Dibenxocyclohepatriene derivatives
CY268A (en) Benzothiadiazine derivatives and their preparation
Mendner Nikodemus
USD185872S (en) Infant's dish
CY253A (en) 6-Chloro-7-Sulphamyl-3:4-Dihydro-1:2:3-Benzothiadiazine-1:1-Dioxide and its salts and the preparation thereof
MY6400099A (en) Steroid compounds and preparation thereof
Pereljman Zanimljiva geometrija
CA557755A (en) Glucosides and the preparation thereof
Šternfeld Veštački zemljini sateliti
Petrović Diferencijalni račun
CA562108A (en) Alkoxybenzylisoquinolines and salts thereof
CA557116A (en) Ar-chloro-ar-hydroxyindanes and the preparation thereof
Becerra-Schmidt Streichquartett No. 1
AU231293B2 (en) Phenothiazines and preparation thereof
AU248312B2 (en) 3:4 dihydro-1:2:4-benzothiadiazine-1:1-dioxides
FR1242720A (en) The stop valve
CA556860A (en) Derivatives of 4,4'-dicarbethoxy-1,1'-ethylenedipiperazine and their salts
CY238A (en) Piperazine salt and its preparation
AU232928B2 (en) 43689/58
AU225811B2 (en) 38940/58
CA555766A (en) 15-hydroxy-testosterone and 10-normethyltestosterone compounds and the 15,17-diacyl derivatives
AU3772258A (en) Phenothiazines and preparation thereof
AU4633259A (en) 3:4 dihydro-1:2:4-benzothiadiazine-1:1-dioxides
CA553675A (en) Babies' high chairs